ENDO PHARMACEUTICALS HOLDINGS INC.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 10, 2003 (April 9, 2003)

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of registrant as specified in its charter)
         
DELAWARE   39040    13-4022871
       
(State or other
jurisdiction of
incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)
         
100 Painters Drive
Chadds Ford, Pennsylvania		     19317  
       
(Address of principal executive offices)     (Zip Code)  

(610) 558-9800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

TABLE OF CONTENTS

Item 5. Other Events.
Item 7. Financial Statements and Exhibits.
SIGNATURES
INDEX TO EXHIBITS
PRESS RELEASE

Table of Contents

Item 5. Other Events.

On April 9, 2003, the Registrant issued a press release, a copy of which is attached as Exhibit 99.1 to this Report and is incorporated herein by reference.

Item 7. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired.

      Not applicable.

(b) Pro Forma Financial Information.

      Not applicable.

(c) Exhibits.

     
Exhibit Number   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated April 9, 2003

 

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

         
    ENDO PHARMACEUTICALS HOLDINGS INC.
    (Registrant)
         
    By:   /s/ CAROL A. AMMON
       
        Name: Carol A. Ammon
Title: Chairman & Chief Executive Officer

Dated: April 10, 2003

 

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated April 9, 2003